A study was conducted to clarify diŠerences in the theophylline pharmacokinetics of two orally available products, theophylline alcohol and Apnecut, in premature neonates and infants using population pharmacokinetic analysis. Fiftytwo patients with apnea hospitalized at the National Center for Child Health and Development were enrolled (total number of plasma concentration points＝90). Population pharmacokinetic analysis under steady-state conditions was performed using NONMEM ver. V. The mean oral clearance was 0.0249 (l/h), and the inter-and intraindividual variation was 30.3％ and 28.3％, respectively, in the basic model. The oral clearance was signiˆcantly aŠected by body weight, sex, and age. Theˆnal model obtained was expressed by the following equation: oral clearance (l/h)＝0.0201× (body weight (g)/1000) 1.08 ×(1-0.282×drug product), where theophylline alcohol is 0 and Apnecut is 1. The interand intraindividual variations in theˆnal model were 15.0％ and 15.3％, respectively. The oral clearance of the two oral formulations diŠered signiˆcantly, and this diŠerence should be considered when adjusting the theophylline dose.
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